Related Experiment Video
Updated: Jul 26, 2026
10:32
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
Summary
General practitioners should refer suspected Parkinson's disease patients to specialists for timely diagnosis and expert medication management. Utilizing nurse specialists in clinics can improve consultant capacity for new patient consultations.
Area of Science:
- Neurology
- Clinical Practice Guidelines
Background:
- Parkinson's disease diagnosis and management require specialized expertise.
- Current general practitioner (GP) practices may lead to delays in diagnosis and suboptimal medication management.
Purpose of the Study:
- To emphasize the importance of specialist referral for suspected Parkinson's disease.
- To advocate for increased GP referrals to specialists and efficient use of healthcare professionals.
Main Methods:
- Review of NICE guidance on Parkinson's disease referral pathways.
- Analysis of potential benefits of specialist-led care and nurse specialist involvement.
Main Results:
- NICE guidance strongly recommends specialist referral for Parkinson's diagnosis.
- Increased GP referrals can expedite patient treatment and expert medication management.
- Nurse specialists can enhance clinic efficiency, allowing consultants to manage more new cases.
Conclusions:
- Timely referral to specialists is crucial for effective Parkinson's disease management.
- Optimizing the roles of GPs, nurse specialists, and consultants can improve patient outcomes and healthcare resource utilization.
More Related Videos
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...